Search This Blog

Wednesday, April 22, 2026

Elevance raises full-year EPS guidance to $26.75

 

Elevance Health beats Q1 2026 estimates with adjusted EPS $12.58, revenue $49.49B, raises full-year EPS guidance to $26.75

  • Q1 2026 adjusted EPS $12.58, increasing 5% year over year
  • Q1 2026 revenue $49.49B, up 1% year over year
  • Board declares second-quarter dividend of $1.72 per share
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)